EnWave presenta los resultados financieros consolidados provisionales del segundo trimestre de 2024
Delta, BC, 24 de mayo de 2024
today reported the Company’s consolidated interim financial results for the second quarter ended March 31, 2024.
All values in thousands and denoted in CAD unless otherwise stated.
- Reported royalty revenues of $414, representing an increase of $137 relative to the comparable period in the prior year. Royalties for the six months ending March 31, 2024 were $894 compared to $690 for the same period ending March 31, 2023, an increase of $204 or 30%. Royalties grew due to increased partner product sales and production offset by a decrease in exclusivity fees.
- Reported revenue for Q2 2023 of $663, representing a decrease of $3,972 relative to the comparable period in the prior year. The decrease was related to fewer machine sales and machines in fabrication due to the inherent volatility in large-scale Radiant Energy Vacuum (“REV™”) machine orders.
- Reported Selling, General & Administrative (“SG&A”) costs (including Research & Development (“R&D”)) of $1,389 which was consistent with the comparable period in the prior year. SG&A costs for the six months ending March 31, 2024 were $2,652 compared to $2,954 for the same period ending March 31, 2023, a decrease of $302 or 10%. The Company continues to make concerted efforts to manage discretionary spending.
- Gross margin for the three months ended Q2 2024 was -25% compared to 49% for the three months ended Q2 2023. The decrease in margin was a result of fewer machine sales and machines in fabrication to absorb fixed overhead costs.
- Reported an Adjusted EBITDA(1) loss of $1,268 for Q2 2024, compared to an Adjusted EBITDA(1) profit of $1,151 in the same period in the prior year.
Consolidated Financial Performance:
($ ‘000s) | Three months ended March 31, | Six months ended March 31, | |||||
2024 | 2023 | Change % | 2024 | 2023 | Change % | ||
Revenues | 663 | 4,635 | (86%) | 1,925 | 7,420 | (74%) | |
Direct costs | (830) | (2,371) | (65%) | (1,859) | (4,127) | (55%) | |
Gross margin | (167) | 2,264 | (107%) | 66 | 3,293 | (98%) | |
Operating expenses | |||||||
General and administration | 565 | 697 | (19%) | 1,076 | 1,252 | (14%) | |
Sales and marketing | 440 | 276 | 59% | 791 | 890 | (11%) | |
Research and development | 384 | 415 | (7%) | 785 | 812 | (3%) | |
1,389 | 1,388 | 0% | 2,652 | 2,954 | (10%) | ||
Net income (loss) continuing operations | (1,559) | 687 | (327%) | (2,703) | (56) | (4727%) | |
Net income (loss) discontinued operations | 148 | (3,386) | 104% | (3) | (4,672) | 100% | |
Adjusted EBITDA(1) | (1,268) | 1,151 | (210%) | (2,024) | 895 | (326%) | |
Loss per share: | |||||||
Basic and diluted – continuous operations | $ (0.01) | $ 0.01 | $ (0.02) | $ 0.00 | |||
Basic and diluted – discontinued operations | $ 0.00 | $ (0.03) | $ 0.00 | $ (0.04) | |||
$ (0.01) | $ (0.02) | $ (0.02) | $ (0.04) |
- Adjusted EBITDA is a non-IFRS financial measure. Refer to the Non-IFRS Financial Measures disclosure below for a reconciliation to the nearest IFRS equivalent.
EnWave’s consolidated interim financial statements and MD&A are available on SEDAR+ at www.sedarplus.ca and on the Company’s website www.enwave.net.
Significant Corporate Accomplishments in Q2 2024 and Subsequently:
- Signed an Equipment Purchase Agreement with an existing Royalty Partner for a 120kW REV™ dehydration machine to commercialize its own branded snack products and co-manufacture new snack and ingredient products with several major consumer packaged goods companies.
- Signed a Technology Evaluation and License Option Agreement with a North American multi-state cannabis company to evaluate REV™ Technology over other incumbent drying methods.
- Signed a toll manufacturing agreement with BranchOut Food Inc. to produce vegetable snack products on an interim basis at the Company’s REVworx facility in Delta, Canada.
- Signed a new royalty-bearing commercial license and equipment lease agreement for two 10kw REV™ machines with an established South American food manufacturer that currently sells health supplements, snacks, cereals, baked goods, among other products.
- Signed a Technology Evaluation and License Option Agreement with a North American food company led by a renowned chef with multiple Michelin Stars.
Medidas financieras distintas de las NIIF:
This news release refers to Adjusted EBITDA which is a non-IFRS financial measure. We define Adjusted EBITDA as earnings before deducting amortization and depreciation, stock-based compensation, foreign exchange gain or loss, finance expense or income, income tax expense or recovery and non-recurring impairment, restructuring and severance charges, and discontinued operations. This measure is not necessarily comparable to similarly titled measures used by other companies and should not be construed as an alternative to net income or cash flow from operating activities as determined in accordance with IFRS. Please refer to the reconciliation between Adjusted EBITDA and the most comparable IFRS financial measure reported in the Company’s consolidated interim financial statements.
Three months ended March 31, | Six months ended March 31, | |||||
($ ‘000s) | 2024 | 2023 | 2024 | 2023 | ||
Net (loss) income after income tax | (1,411) | (2,699) | (2,706) | (4,728) | ||
Amortization and depreciation | 288 | 276 | 563 | 565 | ||
Stock-based compensation | 71 | 197 | 186 | 365 | ||
Foreign exchange loss | (51) | (9) | (27) | 32 | ||
Finance income | (54) | (33) | (106) | (79) | ||
Finance expense | 37 | 33 | 63 | 68 | ||
Discontinued operations | (148) | 3,386 | 3 | 4,672 | ||
Adjusted EBITDA | (1,268) | 1,151 | (2,024) | 895 |
Non-IFRS financial measures should be considered together with other data prepared in accordance with IFRS to enable investors to evaluate the Company’s operating results, underlying performance and prospects in a manner similar to EnWave’s management. Accordingly, these non-IFRS financial measures are intended to provide additional information and should not be considered in isolation or as a substitute for measures of performance prepared in accordance with IFRS. For more information, please refer to the Non-IFRS Financial Measures section in the Company’s MD&A available on SEDAR+ www.sedarplus.ca.
Acerca de EnWave
EnWave es líder mundial en innovación y aplicación de la deshidratación por microondas al vacío. Desde su sede en Delta (Columbia Británica), EnWave ha desarrollado una sólida cartera de propiedad intelectual, ha perfeccionado su tecnología Radiant Energy Vacuum (REV™) y ha transformado una idea innovadora en una solución de secado probada, consistente y escalable para las industrias alimentaria, farmacéutica y del cannabis que supera ampliamente a los métodos de secado tradicionales en eficiencia, capacidad, calidad del producto y coste.
Con más de cincuenta socios generadores de royalties repartidos por veintiséis países y cinco continentes, los socios licenciatarios de EnWave están creando aperitivos e ingredientes rentables y nunca vistos, mejorando la calidad y consistencia de sus ofertas existentes, funcionando de forma más ágil y llegando al mercado más rápidamente con la tecnología patentada de la empresa, la maquinaria bajo licencia y la orientación de expertos.
La estrategia de EnWave consiste en firmar licencias comerciales sujetas a derechos de autor con productores de alimentos que deseen secar mejor, más rápido y de forma más económica que la liofilización, el secado en bastidor y el secado al aire, y disfrutar de las siguientes ventajas: producir productos nuevos e interesantes, alcanzar niveles óptimos de humedad hasta siete veces más rápido y mejorar el sabor, la textura, el color y el valor nutritivo del producto.
Más información en EnWave.net.
Corporación EnWave
Sr. Brent Charleton, CFA
Presidente y Consejero Delegado
Para más información:
Brent Charleton, CFA, Presidente y Director General, +1 (778) 378-9616
Correo electrónico: bcharleton@enwave.net
Dylan Murray, Director Financiero, +1 (778) 870-0729
Correo electrónico: dmurray@enwave.net
Ni la TSX Venture Exchange ni su Proveedor de Servicios de Regulación (según se define este término en las políticas de la TSX Venture Exchange) aceptan responsabilidad alguna por la adecuación o exactitud de este comunicado.